OnCore Login

October 2016

Across the Consortium – October 2016

Oct. 19, 2016:

October is National Breast Cancer Awareness month, and this month’s Across the Consortium illustrates why the Big Ten CRC member institutions are leading the way.  The team is heading off drug resistance at the pass, streamlining preventative measures, developing imaging technology, studying the role of diet, and pioneering treatment strategies where no targeted therapies presently exist.  Catch up with the consortium that’s transforming cancer research through collaboration.

Read More

October is National Breast Cancer Awareness Month

Oct. 5, 2016:

Breast cancer is the second most common kind of cancer in women, behind skin cancer. About 1 in 8 women born today in the United States will get breast cancer at some point, according to the U.S. Department of Health and Human Services. Each year in the United States, more than 200,000 women get breast cancer and more than 40,000 women die from the disease. October is National Breast Cancer Awareness Month — a time to engage, mobilize, and learn — and the Big Ten Cancer Research Consortium brings a wealth of progress to the table.
Read More

Investigators and industry leaders collaborate at Big Ten CRC Summit

Oct. 5, 2016:

The first-ever Big Ten Cancer Research Consortium Summit drew an energetic group of academic investigators and pharmaceutical industry leaders to Indianapolis Sept. 9-10, for a series of meetings that strengthened academic and pharmaceutical industry collaboration within the consortium.

More than 100 attendees, representing all Big Ten CRC member institutions and 16 pharmaceutical and biotech companies, attended the event, hosted by the Indiana University Melvin and Bren Simon Cancer Center. Read More

Member Feature: Masonic Cancer Center, University of Minnesota

Oct. 2, 2016

Investigator Spotlight

Stephen Hecht, Ph.D., is a Carcinogenesis & Chemoprevention Research Program member at screen-shot-2016-10-02-at-4-35-14-pmthe Masonic Cancer Center, University of Minnesota, and a Wallin Land Grant Professor of Cancer Prevention at UMN Department of Laboratory Medicine and Pathology. Dr. Hecht and his laboratory are focused on understanding the ways tobacco smoke constituents cause cancer. To do this he and his colleagues study the mechanisms by which these compounds enter the human body, are metabolized, and ultimately bind to DNA, causing mutations that result in cancer. The goal of Dr. Hecht’s research is two-fold: first, to provide evidence in support of ongoing regulation of tobacco products due to their harm to human health, and second, to find ways to identify the susceptible smoker.

Dr. Hecht has had more than 800 manuscripts published in scientific journals, was elected American Association for the Advancement of Science Fellow in 2014, received the Joseph Cullen Award from the American Society of Preventative Oncology in 2012 and selected as editor-in-chief of Chemical Research in Toxicology in 2012, among a long list of other awards and recognitions.
Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Maryland

University of Maryland

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Wisconsin

University of Wisconsin

University of Illinois at Chicago

University of Illinois at Chicago

© 2024 All rights reserved.

Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278

email: info@bigtencrc.org    phone: 317–921–2050